Regulation of STIM1/Orai1-dependent Ca2+ signalling in platelets

Thrombosis and Haemostasis

Volumn 110, Issue 5, 2013, Pages 925-930

  Lang, Florian ^a   Münzer, Patrick ^a   Gawaz, Meinrad ^a   Borst, Oliver ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ca2+ (arterial thrombosis); Kinases; Platelet physiology; Polymorphisms; Signal transduction

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANTITHROMBOCYTIC AGENT; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOPHILIN A; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN HOMER; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; RECEPTOR FOR ACTIVATED C KINASE 1; SCAFFOLD PROTEIN; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SOMATOMEDIN C; STROMAL INTERACTION MOLECULE 1; THROMBIN; TRANSCRIPTION FACTOR GATA 1; TRANSFORMING GROWTH FACTOR BETA; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UBIQUITIN PROTEIN LIGASE NEDD4; UNINDEXED DRUG;

ARTERY THROMBOSIS; ARTICLE; BLEEDING; BLOOD CLOTTING; CALCIUM SIGNALING; CALCIUM TRANSPORT; DIABETES MELLITUS; GENE TRANSLOCATION; HEART INFARCTION; HUMAN; LIPID RAFT; MEGAKARYOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PH; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TRANSCRIPTION REGULATION;

CA2+ (ARTERIAL THROMBOSIS); KINASES; PLATELET PHYSIOLOGY; POLYMORPHISMS; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD PLATELETS; CALCIUM CHANNELS; CALCIUM SIGNALING; DIABETES MELLITUS, TYPE 2; HUMANS; IMMEDIATE-EARLY PROTEINS; MEMBRANE PROTEINS; METABOLIC SYNDROME X; NEOPLASM PROTEINS; NF-KAPPA B; PLATELET ACTIVATION; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES;

EID: 84886992423     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH13-02-0176     Document Type: Article

References (83)

1. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-1234.
2. Borst O, et al. The inflammatory chaemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signalling. Circ Res 2012; 111: 1297-1307.
3. Bergmeier W, Stefanini L. Novel molecules in calcium signalling in platelets. J Thromb Haemost 2009; 7 (Suppl 1): 187-190.
4. Borst O, et al. The serum-and glucocorticoid-inducible kinase 1 (SGK1) influences platelet calcium signalling and function by regulation of Orai1 expression in megakaryocytes. Blood 2012; 119: 251-261.
5. Gilio K, et al. Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen. J Biol Chem 2010; 285: 23410-23419.
6. Stolla M, et al. The kinetics of alphaIIbbeta3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy. Blood 2011; 117: 1005-1013.
7. Schoenwaelder SM, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood 2009; 114: 663-666.
8. Wolfs JL, et al. Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel. Blood 2006; 108: 2223-2228.
9. Gilio K, et al. Roles of platelet STIM1 and Orai1 in glycoprotein VI-and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem 2010; 285: 23629-23638.
10. Parekh AB. Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov 2010; 9: 399-410.
11. Varga-Szabo D, et al. Calcium signalling in platelets. J Thromb Haemost 2009; 7: 1057-1066.
12. Bergmeier W, et al. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 2009; 113: 675-678.
13. Authi KS. Orai1: a channel to safer antithrombotic therapy. Blood 2009; 113: 1872-1873.
14. Braun A, et al. Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation. Blood 2009; 113: 2056-2063.
15. Feske S. CRAC channelopathies. Pflugers Arch 2010; 460: 417-435.
16. Varga-Szabo D, et al. The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischaemic brain infarction. J Exp Med 2008; 205: 1583-1591.
17. Grosse J, et al. An EF hand mutation in Stim1 causes premature platelet activation and bleeding in mice. J Clin Invest 2007; 117: 3540-3550.
18. Berna-Erro A, et al. Capacitative and non-capacitative signalling complexes in human platelets. Biochim Biophys Acta 2012; 1823: 1242-1251.
19. Le Deist F, et al. A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood 1995; 85: 1053-1062.
20. Ahmad F, et al. Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis. J Thromb Haemost 2011; 9: 2077-2086.
21. Smith KA, Yuan JX. CRACing the cluster: functionally active Orai1 channels in the absence of clustering with STIM1. Circ Res 2012; 111: 9-11.
22. van Kruchten R, et al. Antithrombotic potential of blockers of store-operated calcium channels in platelets. Arterioscler Thromb Vasc Biol 2012; 32: 1717-1723.
23. Galan C, et al. STIM1, Orai1 and hTRPC1 are important for thrombin-and ADP-induced aggregation in human platelets. Arch Biochem Biophys 2009; 490: 137-144.
24. Jardin I, et al. Orai1 mediates the interaction between STIM1 and hTRPC1 and regulates the mode of activation of hTRPC1-forming Ca2+ channels. J Biol Chem 2008; 283: 25296-25304.
25. Jardin I, et al. Store-operated Ca2+ entry is sensitive to the extracellular Ca2+ concentration through plasma membrane STIM1. Biochim Biophys Acta 2009; 1793: 1614-1622.
26. Dobrydneva Y, et al. Diethylstilbestrol and other nonsteroidal estrogens: novel class of store-operated calcium channel modulators. J Cardiovasc Pharmacol 2010; 55: 522-530.
27. Tolios A, et al. Increased platelet Ca2+ channel Orai1 expression upon platelet activation and in patients with acute myocardial infarction. Thromb Haemost 2013; 110: 386-389.
28. Ramanathan G, et al. Defective diacylglycerol-induced Ca2+ entry but normal agonist-induced activation responses in TRPC6-deficient mouse platelets. J Thromb Haemost 2012; 10: 419-429.
29. Jardin I, et al. Dynamic interaction of hTRPC6 with the Orai1-STIM1 complex or hTRPC3 mediates its role in capacitative or non-capacitative Ca(2+) entry pathways. Biochem J 2009; 420: 267-276.
30. Sage SO, et al. TRP channels and calcium entry in human platelets. Blood 2002; 100: 4245-4246.
31. Hassock SR, et al. Expression and role of TRPC proteins in human platelets: evidence that TRPC6 forms the store-independent calcium entry channel. Blood 2002; 100: 2801-2811.
32. Authi KS. TRP channels in platelet function. Handb Exp Pharmacol 2007; 425-443.
33. Dionisio N, et al. Transient receptor potential channels in human platelets: expression and functional role. Curr Mol Med 2012; 12: 1319-1328.
34. Redondo PC, et al. Intracellular Ca2+ store depletion induces the formation of macromolecular complexes involving hTRPC1, hTRPC6, the type II IP3 receptor and SERCA3 in human platelets. Biochim Biophys Acta 2008; 1783: 1163-1176.
35. Baker RG, et al. NF-kappaB, inflammation, and metabolic disease. Cell Metab 2011; 13: 11-22.
36. Ferreira IA, et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 2006; 26: 417-422.
37. Spinelli SL, et al. Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler Thromb Vasc Biol 2010; 30: 591-598.
38. Kim KW, et al. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetateinduced megakaryocytic differentiation of K562 cells. J Biol Chem 2001; 276: 13186-13191.
39. Beaulieu LM, et al. Regulatory effects of TLR2 on megakaryocytic cell function. Blood 2011; 117: 5963-5974.
40. Eylenstein A, et al. Transcription factor NF-kappaB regulates expression of pore-forming Ca2+ channel unit, Orai1, and its activator, STIM1, to control Ca2+ entry and affect cellular functions. J Biol Chem 2012; 287: 2719-2730.
41. Jackson SP, et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 2005; 11: 507-514.
42. Gilio K, et al. Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signalling and thrombus formation. J Biol Chem 2009; 284: 33750-33762.
43. Lian L, et al. The relative role of PLCbeta and PI3Kgamma in platelet activation. Blood 2005; 106: 110-117.
44. Konopatskaya O, et al. PKCalpha regulates platelet granule secretion and thrombus formation in mice. J Clin Invest 2009; 119: 399-407.
45. Moore SF, et al. Dual Regulation of Glycogen Synthase Kinase 3 (GSK3)alpha/beta by Protein Kinase C (PKC)alpha and Akt Promotes Thrombin-mediated Integrin alphaIIbbeta3 Activation and Granule Secretion in Platelets. J Biol Chem 2013; 288: 3918-3928.
46. Chen J, et al. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 2004; 104: 1703-1710.
47. Lang F, et al. (Patho)physiological significance of the serum-and glucocorticoid-inducible kinase isoforms. Physiol Rev 2006; 86: 1151-1178.
48. Schmidt EM, et al. SGK1 sensitivity of platelet migration. Cell Physiol Biochem 2012; 30: 259-268.
49. Zhang L, et al. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating I{kappa}B kinase. Cancer Res 2005; 65: 457-464.
50. Lang F, Shumilina E. Regulation of ion channels by the serum-and glucocorticoid-inducible kinase SGK1. FASEB J 2013; 27: 3-12.
51. Lang F, et al. Targeting SGK1 in diabetes. Expert Opin Ther Targets 2009; 13: 1303-1311.
52. Dahlberg J, et al. Genetic variants in serum and glucocortocoid regulated kinase 1, a regulator of the epithelial sodium channel, are associated with ischaemic stroke. J Hypertens 2011; 29: 884-889.
53. Schmid E, et al. SGK3 regulates Ca(2+) entry and migration of dendritic cells. Cell Physiol Biochem 2012; 30: 1423-1435.
54. Ogawa A, et al. PDGF enhances store-operated Ca2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells. Am J Physiol Cell Physiol 2012; 302: C405-C411.
55. Elvers M, et al. Intracellular cyclophilin A is an important Ca(2+) regulator in platelets and critically involved in arterial thrombus formation. Blood 2012; 120: 1317-1326.
56. Pozo-Guisado E, et al. Phosphorylation of STIM1 at ERK1/2 target sites modulates store-operated calcium entry. J Cell Sci 2010; 123: 3084-3093.
57. Rosado JA, et al. SERCA2b activity is regulated by cyclophilins in human platelets. Arterioscler Thromb Vasc Biol 2010; 30: 419-425.
58. Jardin I, et al. Homers regulate calcium entry and aggregation in human platelets. A role for Homers in the association between STIM1 and Orai1. Biochem J 2012; 445: 29-38.
59. Fleming I, et al. AMP-activated protein kinase (AMPK) regulates the insulin-induced activation of the nitric oxide synthase in human platelets. Thromb Haemost 2003; 90: 863-871.
60. Steinberg GR, Kemp BE. AMPK in Health and Disease. Physiol Rev 2009; 89: 1025-1078.
61. Randriamboavonjy V, et al. AMPK alpha2 subunit is involved in platelet signalling, clot retraction, and thrombus stability. Blood 2010; 116: 2134-2140.
62. Nurbaeva MK, et al. Enhanced Ca(2)(+) entry and Na+/Ca(2)(+) exchanger activity in dendritic cells from AMP-activated protein kinase-deficient mice. FASEB J 2012; 26: 3049-3058.
63. Mungai PT, et al. Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Mol Cell Biol 2011; 31: 3531-3545.
64. Tian G, et al. cAMP induces stromal interaction molecule 1 (STIM1) puncta but neither Orai1 protein clustering nor store-operated Ca2+ entry (SOCE) in islet cells. J Biol Chem 2012; 287: 9862-9872.
65. Lopez E, et al. STIM1 tyrosine-phosphorylation is required for STIM1-Orai1 association in human platelets. Cell Signal 2012; 24: 1315-1322.
66. Bogeski I, et al. Differential redox regulation of ORAI ion channels: a mechanism to tune cellular calcium signalling. Sci Signal 2010; 3: ra24.
67. Pani B, Singh BB. Lipid rafts/caveolae as microdomains of calcium signalling. Cell Calcium 2009; 45: 625-633.
68. Dionisio N, et al. Lipid rafts are essential for the regulation of SOCE by plasma membrane resident STIM1 in human platelets. Biochim Biophys Acta 2011; 1813: 431-437.
69. Marumo M, et al. Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca(2+) entry. Thromb Res 2001; 104: 353-360.
70. Rosado JA. Acidic Ca(2+) stores in platelets. Cell Calcium 2011; 50: 168-174.
71. Zbidi H, et al. STIM1 and STIM2 are located in the acidic Ca2+ stores and associates with Orai1 upon depletion of the acidic stores in human platelets. J Biol Chem 2011; 286: 12257-12270.
72. Bakowski D, et al. Endoplasmic reticulum-mitochondria coupling: local Ca(2+) signalling with functional consequences. Pflugers Arch 2012; 464: 27-32.
73. Oakes SA. Mitochondria control calcium entry at the immunological synapse. Proc Natl Acad Sci USA 2007; 104: 15171-15172.
74. Eylenstein A, et al. Stimulation of Ca2+-channel Orai1/STIM1 by serum-and glucocorticoid-inducible kinase 1 (SGK1). FASEB J 2011; 25: 2012-2021.
75. Woodard GE, et al. TRPC3 regulates agonist-stimulated Ca2+ mobilisation by mediating the interaction between type I inositol 1, 4, 5-trisphosphate receptor, RACK1, and Orai1. J Biol Chem 2010; 285: 8045-8053.
76. Zbidi H, et al. Enhanced expression of STIM1/Orai1 and TRPC3 in platelets from patients with type 2 diabetes mellitus. Blood Cells Mol Dis 2009; 43: 211-213.
77. Alexandru N, et al. Platelet free cytosolic calcium concentration during ageing of type 2 diabetic patients. Platelets 2007; 18: 473-480.
78. El Haouari M, Rosado JA. Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review. Blood Cells Mol Dis 2008; 41: 119-123.
79. Jardin I, et al. Attenuated store-operated divalent cation entry and association between STIM1, Orai1, hTRPC1 and hTRPC6 in platelets from type 2 diabetic patients. Blood Cells Mol Dis 2011; 46: 252-260.
80. Lu KC, et al. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure. Q J Med 1994; 87: 359-365.
81. Ware JA, et al. Abnormalities of cytoplasmic Ca2+ in platelets from patients with uremia. Blood 1989; 73: 172-176.
82. Gawaz M. Intelligent platelet inhibitors are on the horizon. Arterioscler Thromb Vasc Biol 2011; 31: 1949-1950.
83. Lang F, Voelkl J. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition. Expert Opin Investig Drugs 2013; in press.